Related Experiment Video
Updated: Jun 23, 2026

MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication
Engin Gürlevik1, Norman Woller, Peter Schache
1Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Carl Neuberg Str. 1, 30625 Hannover, Germany.
Abstract:
RNA-interference (RNAi) is a potent tool for specific gene silencing. In this study, we developed an adenovirus for conditional replication in p53-dysfunctional tumor cells that uses p53-selective expression of a microRNA-network directed against essential adenoviral genes. Compared to a control virus that expressed a scrambled microRNA-network, antiviral RNAi selectively attenuated viral replication in cells with transcriptionally active p53, but not in p53-dysfunctional tumor cells where both viruses replicated equivalently. Since these results were confirmed by an in vivo comparison of both viruses after infection of p53-knockout and normal mice, we could demonstrate that attenuated replication was indeed a result of p53-selective exhibition of antiviral RNAi. Addressing the therapeutic applicability, we could show that the application of RNAi-controlled virus efficiently lysed p53-dysfunctional tumors in vitro and in vivo but resulted in drastically reduced load of virus-DNA in the liver of treated mice. We have generated a broadly applicable adenovirus for selective destruction of p53-dysfunctional tumors and thereby demonstrate that virus-encoded RNAi-networks represent an efficient and versatile tool to modify viral functions. RNAi-networks can be applied to all transcriptionally regulated DNA-viruses to remodulate viral tropism and thus provide means to generate specifically replicating vectors for clinical applications.
Insights
This study developed an adenovirus using RNA-interference (RNAi) to target p53-dysfunctional tumors. The novel virus selectively replicates in and lyses these tumors while minimizing liver viral load, offering a promising cancer therapy.
Area of Science:
- Oncolytic virotherapy
- Molecular biology
- Gene therapy
Background:
- RNA-interference (RNAi) enables specific gene silencing.
- Adenoviruses are utilized as vectors for gene therapy and cancer treatment.
- p53 tumor suppressor protein plays a critical role in cell cycle regulation and apoptosis.
Purpose of the Study:
- To engineer an adenovirus for conditional replication in p53-dysfunctional tumor cells.
- To utilize a microRNA-network for p53-selective gene silencing of essential viral genes.
- To evaluate the therapeutic efficacy and safety of the developed oncolytic virus.
Main Methods:
- Development of a replication-conditional adenovirus expressing a p53-selective microRNA-network.
- In vitro and in vivo assessment of viral replication in p53-dysfunctional and normal cells/mice.
- Evaluation of tumor lysis and viral DNA load in liver tissues.
Main Results:
- Antiviral RNAi selectively attenuated viral replication in cells with transcriptionally active p53.
- Both control and engineered viruses replicated equivalently in p53-dysfunctional tumor cells.
- The RNAi-controlled virus efficiently lysed p53-dysfunctional tumors in vitro and in vivo with reduced liver viral DNA load.
Conclusions:
- A broadly applicable adenovirus for selective destruction of p53-dysfunctional tumors was generated.
- Virus-encoded RNAi-networks are efficient and versatile tools to modify viral functions.
- This approach can be applied to transcriptionally regulated DNA-viruses to create specifically replicating vectors for clinical applications.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Abnormal Proliferation
Experimental RNAi
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Viruses with RNA Genomes

